Curcumin for adults with sepsis in the ICU
Treatments studied
Part of Infections clinical trials.
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis and are in the ICU at the study hospital
- You are getting nutrition through a feeding tube
- You or your family can sign a consent form
- You are not allergic to turmeric or curcumin
- You do not have a condition that prevents you from using a feeding tube
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
This trial tests whether giving very high doses of vitamin D can help adults with sepsis who are in the intensive care unit (ICU). It looks at whether this treatment improves recovery and outcomes.
This trial tests if a specific form of vitamin D can improve recovery for patients with severe infections (sepsis) in the intensive care unit. The vitamin D may help control inflammation and support the immune system.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial tests if a fecal microbiota transplant (FMT) can improve survival and recovery in ICU patients with sepsis. FMT involves transferring healthy donor bacteria into your gut to help fight severe infection.
This trial is testing several different treatments to find the best one for each person with sepsis. It looks at specific 'treatable traits' like inflammation, blood clotting problems, or immune system issues to match you with the right therapy. The goal is to improve recovery and survival.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.